- Home
- CME vs BMY Comparison
CME vs BMY Comparison
Compare CME & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CME
- BMY
- Stock Information
- Founded
- CME 1898
- BMY 1887
- Country
- CME United States
- BMY United States
- Employees
- CME N/A
- BMY N/A
- Industry
- CME Investment Bankers/Brokers/Service
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- CME Finance
- BMY Health Care
- Exchange
- CME Nasdaq
- BMY Nasdaq
- Market Cap
- CME 101.4B
- BMY 99.7B
- IPO Year
- CME 2002
- BMY N/A
- Fundamental
- Price
- CME $265.40
- BMY $47.37
- Analyst Decision
- CME Hold
- BMY Hold
- Analyst Count
- CME 15
- BMY 15
- Target Price
- CME $261.93
- BMY $57.64
- AVG Volume (30 Days)
- CME 1.8M
- BMY 9.9M
- Earning Date
- CME 10-22-2025
- BMY 10-30-2025
- Dividend Yield
- CME 4.07%
- BMY 5.23%
- EPS Growth
- CME 13.89
- BMY N/A
- EPS
- CME 10.33
- BMY 2.49
- Revenue
- CME $6,432,700,000.00
- BMY $47,704,000,000.00
- Revenue This Year
- CME $7.58
- BMY N/A
- Revenue Next Year
- CME $4.16
- BMY N/A
- P/E Ratio
- CME $25.67
- BMY $19.06
- Revenue Growth
- CME 11.14
- BMY 2.57
- 52 Week Low
- CME $207.75
- BMY $42.96
- 52 Week High
- CME $290.79
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- CME 35.57
- BMY 50.93
- Support Level
- CME $268.54
- BMY $46.65
- Resistance Level
- CME $273.23
- BMY $47.84
- Average True Range (ATR)
- CME 3.83
- BMY 0.91
- MACD
- CME -1.00
- BMY -0.03
- Stochastic Oscillator
- CME 19.38
- BMY 31.58
About CME CME Group Inc.
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.